NEWSROOM
August 21, 2017
In order to encourage research collaboration with Swiss research groups, CTI provided an innovation grant to SunRegen to collaborate with the Brain Mind Institute (BMI) in École polytechnique fédérale de Lausanne (EPFL). The collaboration with EPFL will greatly expand the research capability of SunRegen.
SunRegen Healthcare AG is a biopharmaceutical company to develop drugs for the unmet medical needs of Neurodegenerative diseases and ophthalmic diseases.
SunRegen Healthcare AG
Business Parc Reinach
Christoph Merian-Ring 11, 4153 Reinach Switzerland
Copyright © 2025, SunRegen Healthcare AG